肺癌
药品
医学
肿瘤科
内科学
重症监护医学
药理学
作者
Khurram Haq Nawaz,Rachel M. Webster
摘要
The year 2015 saw the approval of six new targeted therapies for the treatment of non-small-cell lung cancer (NSCLC). This analysis discusses recently approved as well as late-stage compounds and examines how different drug classes will affect the NSCLC market.
科研通智能强力驱动
Strongly Powered by AbleSci AI